ICD-10-CM · General

M33.90

M33.90 identifies dermatopolymyositis that is unspecified as to subtype (juvenile, adult, or polymyositis) and with no documented organ system involvement recorded.

Verified May 8, 2026 · 7 sources ↓

Status
Billable
Chapter
13
Related CPT
5
Region
General
Drawn from CDCICD10DataAAPCOutsourcestrategiesIcd10coded

Documentation tips

What should appear in the chart to support M33.90.

Source · Editorial brief grounded in 7 cited references ↓

  • Document patient age and onset pattern explicitly — 'juvenile' versus 'adult-onset' — so the coder can choose M33.0x, M33.1x, or M33.9x with confidence.
  • Record presence or absence of myopathy directly: note CK/aldolase levels, EMG results, or muscle biopsy findings to support moving from M33.90 to M33.92 (with myopathy) or M33.93 (without myopathy).
  • State whether organ system involvement has been evaluated and ruled out, or is still pending workup — 'organ involvement not yet assessed' is actionable for the coder; silence is not.
  • If pulmonary involvement is identified (ILD, aspiration risk, respiratory muscle weakness), document it explicitly so M33.91 can be assigned instead of M33.90.
  • When myositis-specific antibodies (e.g., anti-Jo-1, anti-Mi-2, anti-MDA5) are resulted, include them in the note — positive antibody panels support a more specific subtype assignment and reduce audit exposure on the unspecified code.

Related CPT procedures

Procedure codes commonly billed with M33.90. Linking the right diagnosis to the right procedure is what establishes medical necessity.

Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis

Common coding pitfalls

The recurring mistakes coders make with M33.90 and adjacent codes.

Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓

  • Defaulting to M33.90 when antibody results or muscle enzyme levels already in the chart support a more specific sibling code — M33.92 (with myopathy) or M33.93 (without myopathy) — is undercoding and an audit flag.
  • Confusing M33.9 (the non-billable parent) with M33.90 (the billable child); submitting M33.9 alone will result in claim rejection.
  • Failing to add secondary codes for documented manifestations — for example, J84.10 for pulmonary fibrosis or M79.1 for myalgia — when those conditions are treated or managed at the same encounter.
  • Applying M33.90 to a known adult dermatomyositis patient just because the record says 'dermatomyositis' without subtype detail, when a prior encounter already established M33.1x; consistency of diagnosis coding across encounters matters for payer review.
  • Including the decimal point when submitting claims electronically — file as M3390, not M33.90, to avoid clearinghouse rejection.

Clinical context

Source · Editorial summary grounded in 7 cited references ↓

M33.90 is the fallback code within category M33 when the clinical record does not distinguish between juvenile dermatomyositis, other (adult) dermatomyositis, or polymyositis — and also fails to document specific organ involvement. It sits under parent M33.9 (Dermatopolymyositis, unspecified) and is the least specific billable code in the M33 family. Use it only when the encounter note genuinely lacks the detail needed to assign a more precise sibling code.

In practice, M33.90 should be a rare assignment. If the provider documents muscle weakness or elevated CK consistent with myopathy, move to M33.92. If respiratory involvement (e.g., ILD, pulmonary fibrosis) is documented, use M33.91. If the patient is a confirmed adult with dermatomyositis and no myopathy, M33.13 or M33.12 under M33.1 is the better fit. If the patient is a child with confirmed juvenile dermatomyositis, M33.00–M33.09 applies. Reserve M33.90 for truly undifferentiated presentations — for example, an initial rheumatology referral where the inflammatory myopathy subtype has not yet been established and organ workup is pending.

M33.90 maps to MS-DRG MDC 08 (Diseases and Disorders of the Musculoskeletal System and Connective Tissue), clustering into DRG 545/546/547 based on CC/MCC status. Research data note that the ICD-10 code M33.9 as a group carries a lower positive predictive value (PPV ~0.57) for true dermatomyositis compared to more specific M33.1x codes (PPV ~0.94), which underscores the coding pressure to get to the most specific subcategory the documentation supports.

Sibling codes

Other billable codes under M33.9 (laterality / anatomic variants).

Frequently asked questions

Source · Generated from the editorial pipeline, verified against 7 cited references ↓

01When is M33.90 the correct code and not just a lazy default?
M33.90 is correct when the inflammatory myopathy subtype is genuinely undifferentiated — such as an initial visit before workup results return — and no organ involvement has been documented or evaluated. Once the chart contains CK levels, biopsy findings, antibody panels, or organ system data, a more specific sibling code is required.
02What is the difference between M33.9 and M33.90?
M33.9 is the non-billable parent category for 'Dermatopolymyositis, unspecified.' M33.90 is the billable fifth-character code specifying that organ involvement is also unspecified. Always bill M33.90, never M33.9 alone.
03Can M33.90 be used for a patient with known adult dermatomyositis?
Only if subtype and organ involvement truly cannot be determined from the record. If the provider has previously documented adult-onset dermatomyositis with or without myopathy, the appropriate code is under M33.1x (Other dermatomyositis), not M33.9x.
04Should secondary codes be added when billing M33.90?
Yes. Code any documented and treated manifestations separately — J84.10 for pulmonary fibrosis, M79.1 for myalgia, or others as clinically relevant. M33.90 does not capture organ-level complications by itself.
05Which MS-DRG does M33.90 map to?
M33.90 maps to MDC 08 (Musculoskeletal System and Connective Tissue), DRG 545 with MCC, DRG 546 with CC, or DRG 547 without CC/MCC, depending on comorbidity and complication documentation.
06Is M33.90 appropriate for paraneoplastic dermatomyositis?
No. Dermatomyositis associated with a confirmed malignancy should be coded M36.0 (Dermatomyositis in neoplastic disease), with an additional code for the underlying malignancy. M33.90 does not capture the paraneoplastic etiology.
07What documentation distinguishes M33.90 from M33.92?
M33.92 requires documented myopathy — clinical evidence of proximal muscle weakness, elevated muscle enzymes (CK, aldolase), abnormal EMG, or muscle biopsy findings. If any of those are present and documented, use M33.92, not M33.90.

Mira AI Scribe

Mira's AI scribe captures the clinical details that move this code off the unspecified default: patient age and onset (juvenile vs. adult), documented presence or absence of muscle weakness, CK/aldolase values, myositis-specific antibody results, pulmonary function findings, and any organ system workup status. Capturing those elements at the point of care prevents downcoding to M33.90 when a more specific M33 subcategory is clinically supported — and reduces the audit risk associated with the lower diagnostic PPV of the M33.9 unspecified group.

See how Mira captures M33.90 documentation

Related ICD-10 codes

Ready?

Ready to transform your orthopedic practice?

See how orthopedic practices are running documentation, billing, and operations on a single voice-first platform.

Get started for free